Home » Topics » BioWorld Science

BioWorld Science
RSS

Identification of genetic prognosticators in glioblastoma survivors by NGS

Aug. 9, 2018

FDA approves Poteligeo for two subtypes of cutaneous T-cell lymphoma

Aug. 9, 2018

Positive data announced from phase II extension study of MVA-BN RSV universal vaccine

Aug. 9, 2018

Description of a phase I study evaluating locoregional immunotherapy for ovarian cancer recurrence

Aug. 9, 2018

Medshine Discovery synthesizes WEE1hu inhibitors

Aug. 9, 2018

Researchers present new NR1I2 agonists

Aug. 9, 2018

Bayer patents MKNK1 inhibitors

Aug. 9, 2018

Phase III study of Estelle oral contraceptive meets primary efficacy endpoint

Aug. 9, 2018

Immunose FLU nasal influenza vaccine candidate demonstrates good safety in older adults

Aug. 9, 2018

First participant enrolled in phase III study of M-001 universal flu vaccine candidate

Aug. 9, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...